Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Valeant Pharmaceuticals Intl Inc    VRX   CA91911K1021

VALEANT PHARMACEUTICALS INTL INC (VRX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Valeant Pharmaceuticals Intl : Health Care Higher As Paulson Joins Valeant Board - Health Care Roundup

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/19/2017 | 10:31pm CEST

Shares of health-care companies rose as one big investor endorsed one of the hardest hit companies during the recent retreat from the sector. Hedge-fund billionaire John Paulson joined the board of Valeant Pharmaceuticals International, a sign that the investor remains bullish on the drugmaker's prospects despite the rout in Valeant's shares over the last year. The specialty drugmaker came under pressure after allegations of accounting improprieties and lost the support of some big institutional holders, such as William Ackman's Pershing Square. Medical-test maker PerkinElmer said it would buy a German medical-diagnostics company Euroimmun Medical Laboratory Diagnostics for $1.3 billion, expanding its reach into autoimmune and allergy testing.

-Rob Curran, [email protected]

Stocks mentioned in the article
ChangeLast1st jan.
VALEANT PHARMACEUTICALS INTL INC 0.57% 28.4 Delayed Quote.7.79%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on VALEANT PHARMACEUTICALS IN
12:20aWILLIAM ACKMAN : Ackman makes roughly $1 billion bet on Lowe's
RE
05/23VALEANT PHARMACEUTICALS INTL : Ex-Valeant Executive Convicted In Scheme -- WSJ
DJ
05/22VALEANT PHARMACEUTICALS INTL : Ex-Valeant, Philidor executives convicted of kick..
RE
05/22VALEANT PHARMACEUTICALS INTL : Former Valeant Executive Found Guilty on Charges ..
DJ
05/22VALEANT PHARMACEUTICALS INTL : Former Valeant Executive And Former Philidor Ceo ..
AQ
05/21VALEANT PHARMACEUTICALS INTL : Announces Launch Of Private Offering Of Notes And..
AQ
05/21VALEANT PHARMACEUTICALS INTL : Announces Pricing Of Private Offering Of Notes
AQ
05/17VALEANT PHARMACEUTICALS INTL : Will Become Bausch Health Companies Inc.
AQ
05/17VALEANT PHARMACEUTICALS INTERNATIONA : Other Events (form 8-K)
AQ
05/17VALEANT PHARMACEUTICALS INTL : Announces Pricing Of Private Offering Of Notes
PR
More news
Financials ($)
Sales 2018 8 508 M
EBIT 2018 3 067 M
Net income 2018 -3 544 M
Debt 2018 23 708 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 3,69x
EV / Sales 2019 3,59x
Capitalization 7 719 M
Chart VALEANT PHARMACEUTICALS IN
Duration : Period :
Valeant Pharmaceuticals In Technical Analysis Chart | VRX | CA91911K1021 | 4-Traders
Technical analysis trends VALEANT PHARMACEUTICALS IN
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 16
Average target price 16,9 $
Spread / Average Target -24%
EPS Revisions
Managers
NameTitle
Joseph C. Papa Chairman & Chief Executive Officer
Paul S. Herendeen Chief Financial Officer & Executive Vice President
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
David Robert Hale Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
VALEANT PHARMACEUTICALS INTL INC6.21%7 719
JOHNSON & JOHNSON-11.45%331 111
PFIZER-1.16%210 409
NOVARTIS-6.94%200 805
ROCHE HOLDING LTD.-9.17%191 486
MERCK AND COMPANY3.87%159 185